[go: up one dir, main page]

NO20021565L - Bicykliske imidazo-3-yl-aminderivater - Google Patents

Bicykliske imidazo-3-yl-aminderivater

Info

Publication number
NO20021565L
NO20021565L NO20021565A NO20021565A NO20021565L NO 20021565 L NO20021565 L NO 20021565L NO 20021565 A NO20021565 A NO 20021565A NO 20021565 A NO20021565 A NO 20021565A NO 20021565 L NO20021565 L NO 20021565L
Authority
NO
Norway
Prior art keywords
amine derivatives
bicyclic imidazo
imidazo
bicyclic
amine
Prior art date
Application number
NO20021565A
Other languages
English (en)
Other versions
NO20021565D0 (no
NO322754B1 (no
Inventor
Matthias Gerlach
Corinna Maul
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19948434A external-priority patent/DE19948434A1/de
Priority claimed from DE1999148438 external-priority patent/DE19948438B4/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20021565D0 publication Critical patent/NO20021565D0/no
Publication of NO20021565L publication Critical patent/NO20021565L/no
Publication of NO322754B1 publication Critical patent/NO322754B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20021565A 1999-10-08 2002-04-03 Bicykliske imidazo-3-yl-aminderivater, legemiddel inneholdende disse, deres anvendelse for fremstilling av et legemiddel samt en fremgangsmate for fremstilling av derivatene. NO322754B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19948434A DE19948434A1 (de) 1999-10-08 1999-10-08 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
DE1999148438 DE19948438B4 (de) 1999-10-08 1999-10-08 Bicyclische Imidazo-3-aminderivate
PCT/EP2000/009096 WO2001027111A2 (de) 1999-10-08 2000-09-18 Bicyclische imidazo-3-yl-aminderivate

Publications (3)

Publication Number Publication Date
NO20021565D0 NO20021565D0 (no) 2002-04-03
NO20021565L true NO20021565L (no) 2002-05-27
NO322754B1 NO322754B1 (no) 2006-12-04

Family

ID=26055218

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021565A NO322754B1 (no) 1999-10-08 2002-04-03 Bicykliske imidazo-3-yl-aminderivater, legemiddel inneholdende disse, deres anvendelse for fremstilling av et legemiddel samt en fremgangsmate for fremstilling av derivatene.

Country Status (26)

Country Link
US (1) US6638933B2 (no)
EP (1) EP1218382B1 (no)
JP (1) JP2003511451A (no)
KR (1) KR100756592B1 (no)
CN (1) CN1257169C (no)
AR (1) AR025962A1 (no)
AT (1) ATE258554T1 (no)
AU (1) AU779197B2 (no)
BR (1) BR0014818A (no)
CA (1) CA2382919C (no)
CO (1) CO5251378A1 (no)
CZ (1) CZ20021210A3 (no)
DE (1) DE50005155D1 (no)
DK (1) DK1218382T3 (no)
ES (1) ES2213611T3 (no)
HK (1) HK1047747B (no)
HU (1) HUP0203052A3 (no)
NO (1) NO322754B1 (no)
NZ (2) NZ518439A (no)
PE (1) PE20010634A1 (no)
PL (1) PL355206A1 (no)
PT (1) PT1218382E (no)
RU (1) RU2264402C2 (no)
SK (1) SK286788B6 (no)
UY (1) UY26372A1 (no)
WO (1) WO2001027111A2 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
DE10043845A1 (de) * 2000-09-06 2002-03-14 Gruenenthal Gmbh Verfahren zur Messung der Aktivität der NO-Synthase
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2002048146A2 (de) * 2000-12-13 2002-06-20 Basf Aktiengesellschaft Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2002364082A1 (en) 2001-12-19 2003-07-09 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
DE102004021716A1 (de) * 2004-04-30 2005-12-01 Grünenthal GmbH Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
CA2570073A1 (en) * 2004-06-09 2005-12-22 Oncalis Ag Protein kinase inhibitors
US7923041B2 (en) * 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
DE602006012815D1 (de) * 2005-03-23 2010-04-22 Hoffmann La Roche Acetylenylpyrazolopyrimidinderivate als mglur2-antagonsten
WO2006125101A2 (en) * 2005-05-20 2006-11-23 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
EP1901748B1 (en) * 2005-06-09 2010-09-08 Oncalis AG Angiogenesis inhibitors
WO2007028051A2 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
US7399769B2 (en) * 2005-12-27 2008-07-15 Hoffmann-La Roche Inc. Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives
BRPI0706560A2 (pt) * 2006-01-17 2011-03-29 Hoffmann La Roche derivados de aril-isoxazol-4-il-imidazo [1,2-a] piridina úteis para o tratamento de doença de alzheimer por intermédio de receptores gaba
EP1845098A1 (en) * 2006-03-29 2007-10-17 Ferrer Internacional, S.A. Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
DK2029602T3 (da) * 2006-05-31 2010-08-09 Galapagos Nv Triazolopyrazinforbindelser, der kan anvendes til behandling af degenerative og inflammatoriske sygdomme
US8227603B2 (en) * 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
WO2008016648A2 (en) * 2006-08-01 2008-02-07 Cytokinetics, Incorporated Certain chemical entities, compositions and methods
AU2007281468B2 (en) * 2006-08-02 2012-12-06 Cytokinetics, Incorporated Certain chemical entities, compositions and methods
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
EP1974729A1 (en) * 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
US7851484B2 (en) * 2007-03-30 2010-12-14 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
GB0708188D0 (en) * 2007-04-27 2007-06-06 Merck Sharp & Dohme Therapeutic compounds
WO2009128383A1 (ja) * 2008-04-15 2009-10-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 ３－フェニルピラゾロ［５，１－ｂ］チアゾール化合物
MX2011000355A (es) * 2008-07-10 2011-04-07 Southern Res Inst Compuestos de 5-quinolinona e imidazopirimidina y utilizacion de los mismos.
WO2010032195A1 (en) * 2008-09-16 2010-03-25 Csir Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
SG171972A1 (en) 2008-12-05 2011-07-28 Inviragen Inc Compositions, methods and uses for inducing viral growth
AR078521A1 (es) * 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
CN109316480A (zh) 2011-07-13 2019-02-12 赛特凯恩蒂克公司 组合als疗法
EP2920169A1 (en) * 2012-11-14 2015-09-23 F. Hoffmann-La Roche AG Imidazopyridine derivatives
HUE035966T2 (en) * 2013-03-14 2018-05-28 Galapagos Nv Compounds and compositions for the treatment of inflammatory diseases
WO2017160922A1 (en) 2016-03-16 2017-09-21 Kalyra Pharmaceuticals, Inc. Analgesic compounds
CA3057684A1 (en) * 2017-04-28 2018-11-01 Dana-Farber Cancer Institute, Inc. Inhibitors of trim33 and methods of use
US11530209B2 (en) 2017-10-04 2022-12-20 Dana-Farber Cancer Institute, Inc. Small molecule inhibition of transcription factor SALL4 and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
EP0266890A1 (en) * 1986-10-07 1988-05-11 Yamanouchi Pharmaceutical Co. Ltd. Imidazopyridine derivatives, their production, and pharmaceutical compositions containing them
RU2043716C1 (ru) * 1989-06-23 1995-09-20 Такеда Кемикал Индастриз Лтд. Амидное производное и фунгицидный состав на его основе
NZ238863A (en) * 1990-07-19 1993-03-26 Janssen Pharmaceutica Nv Substituted thiazolyl and pyridinyl derivatives
TW274551B (no) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
DE4327027A1 (de) * 1993-02-15 1994-08-18 Bayer Ag Imidazoazine
KR19990007836A (ko) * 1995-04-21 1999-01-25 다나까 테츠오 융합된 이미다조[1, 2-a]피리딘
WO2002002557A2 (en) * 2000-06-30 2002-01-10 Neurogen Corporation 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands

Also Published As

Publication number Publication date
AU7777100A (en) 2001-04-23
BR0014818A (pt) 2002-06-18
PE20010634A1 (es) 2001-07-07
HUP0203052A3 (en) 2004-06-28
PT1218382E (pt) 2004-06-30
KR100756592B1 (ko) 2007-09-10
CO5251378A1 (es) 2003-02-28
HK1047747A1 (zh) 2003-03-07
US20030018032A1 (en) 2003-01-23
SK4362002A3 (en) 2002-08-06
PL355206A1 (en) 2004-04-05
WO2001027111A3 (de) 2001-06-14
CN1391573A (zh) 2003-01-15
CN1257169C (zh) 2006-05-24
NZ518390A (en) 2003-10-31
HK1047747B (zh) 2004-12-03
HUP0203052A2 (hu) 2003-01-28
NZ518439A (en) 2003-10-31
SK286788B6 (sk) 2009-05-07
UY26372A1 (es) 2000-12-29
US6638933B2 (en) 2003-10-28
JP2003511451A (ja) 2003-03-25
WO2001027111A2 (de) 2001-04-19
AU779197B2 (en) 2005-01-13
DE50005155D1 (de) 2004-03-04
DK1218382T3 (da) 2004-03-22
ES2213611T3 (es) 2004-09-01
KR20020038805A (ko) 2002-05-23
NO20021565D0 (no) 2002-04-03
CA2382919A1 (en) 2001-04-19
EP1218382B1 (de) 2004-01-28
EP1218382A2 (de) 2002-07-03
CZ20021210A3 (cs) 2002-08-14
NO322754B1 (no) 2006-12-04
ATE258554T1 (de) 2004-02-15
CA2382919C (en) 2008-12-09
AR025962A1 (es) 2002-12-26
RU2264402C2 (ru) 2005-11-20

Similar Documents

Publication Publication Date Title
ATE258554T1 (de) Bicyclische imidazo-3-yl-aminderivate
FR15C0096I2 (fr) Derives carbamoyloxyalkyl-azolium n-substitues
ATE413403T1 (de) Bicyclische imidazo-5-yl-aminderivate
NO20000885L (no) 4-Fenyl-pyridin-derivater
NO20021077L (no) Amino-triazolopyridin-derivater
DE60009747D1 (de) Admantan-derivate
ATE293104T1 (de) Thiazolylamid-derivate
IS6128A (is) 13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE270270T1 (de) Neuartige phenylalkyloxy-phenyl-derivate
ATE257148T1 (de) Propargyletherderivate
ATE273272T1 (de) Mevinolinderivate
ATE374747T1 (de) Monofluoralkylderivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
DK1218340T3 (da) 4-hydroxybiphenylhydrazid-derivater
ATE293592T1 (de) Resorcinderivate
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
NO20021310D0 (no) Aminderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees